Physicochemical evaluation of nanoparticles assembled from poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) block copolymers as drug delivery vehicles

被引:255
作者
Riley, T
Stolnik, S
Heald, CR
Xiong, CD
Garnett, MC
Illum, L
Davis, SS
Purkiss, SC
Barlow, RJ
Gellert, PR
机构
[1] Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England
[2] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England
关键词
D O I
10.1021/la001226i
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nanoparticles assembled from poly(D,L-lactic acid)-poly(ethylene glycol) (PLA-PEG) block copolymers may have a therapeutic application in site-specific drug delivery. A series of AB block copolymers based on a fixed PEG block (5 kDa) and a varying PLA segment (2-110 kDa) have been synthesized by the ring-opening polymerization of D,L-lactide using stannous octoate as a catalyst. These copolymers assembled to form spherical nanoparticles in aqueous media following precipitation from a water-miscible organic solvent. H-1 NMR studies of the PLA-PEG nanoparticles in D2O confirmed their core-shell structure, with negligible penetration of the hydrated PEG chains into the PLA core. The influence of the PLA block molecular weight on the hydrodynamic size and micellar aggregation number of the assemblies was determined by dynamic and static light scattering techniques. The hydrodynamic radius of the PLA-PEG 2:5-30:5 nanoparticles was solely dependent on the copolymer architecture and scaled linearly as N-PLA(1/3) where N-PLA is the number of monomeric units in the PLA block. The PEG chains of the small PLA-PEG 2:5 and 3:5 assemblies appeared to be fairly splayed as a consequence of their relatively low aggregation number and high surface coverage. However, as NPLA was increased to 6 kDa the area available per PEG chain at the periphery of the shell decreased significantly and then remained fairly constant with further increases in the molecular weight of the PLA block. The aggregation number and hence particle size of nanoparticles produced from copolymers with a PLA block of 45 kDa or more was found to also depend on the concentration of copolymer dissolved in the organic phase during preparation. This suggested that that the PEG chains had little influence on the assembly of the higher molecular weight copolymers.
引用
收藏
页码:3168 / 3174
页数:7
相关论文
共 51 条
  • [1] STEALTH ME.PEG-PLA NANOPARTICLES AVOID UPTAKE BY THE MONONUCLEAR PHAGOCYTES SYSTEM
    BAZILE, D
    PRUDHOMME, C
    BASSOULLET, MT
    MARLARD, M
    SPENLEHAUER, G
    VEILLARD, M
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) : 493 - 498
  • [2] Chu B., 1991, LASER LIGHT SCATTERI, V2nd
  • [3] CHURCHILL JR, 1983, Patent No. 00166596
  • [4] STUDIES ON THE BLOCK COPOLYMERIZATION OF D,L-LACTIDE AND POLY(ETHYLENE GLYCOL) WITH ALUMINUM COMPLEX CATALYST
    DENG, XM
    XIONG, CD
    CHENG, LM
    HUANG, HH
    XU, RP
    [J]. JOURNAL OF APPLIED POLYMER SCIENCE, 1995, 55 (08) : 1193 - 1196
  • [5] ASYMPTOTIC-BEHAVIOR AND LONG-RANGE INTERACTIONS IN AQUEOUS-SOLUTIONS OF POLY(ETHYLENE OXIDE)
    DEVANAND, K
    SELSER, JC
    [J]. MACROMOLECULES, 1991, 24 (22) : 5943 - 5947
  • [6] POLYSTYRENE-POLY(ETHYLENE GLYCOL) (PS-PEG2000) PARTICLES AS MODEL SYSTEMS FOR SITE-SPECIFIC DRUG-DELIVERY .2. THE EFFECT OF PEG SURFACE-DENSITY ON THE IN-VITRO CELL-INTERACTION AND IN-VIVO BIODISTRIBUTION
    DUNN, SE
    BRINDLEY, A
    DAVIS, SS
    DAVIES, MC
    ILLUM, L
    [J]. PHARMACEUTICAL RESEARCH, 1994, 11 (07) : 1016 - 1022
  • [7] FESSI H, Patent No. 2608988
  • [8] Defining the drug incorporation properties of PLA-PEG nanoparticles
    Govender, T
    Riley, T
    Ehtezazi, T
    Garnett, MC
    Stolnik, S
    Illum, L
    Davis, SS
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 199 (01) : 95 - 110
  • [9] THE CONTROLLED INTRAVENOUS DELIVERY OF DRUGS USING PEG-COATED STERICALLY STABILIZED NANOSPHERES
    GREF, R
    DOMB, A
    QUELLEC, P
    BLUNK, T
    MULLER, RH
    VERBAVATZ, JM
    LANGER, R
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) : 215 - 233
  • [10] GREF R, 1994, SCIENCE, V7, P359